key: cord-0773050-q92q8zql
authors: Shors, Andrew R.
title: Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection
date: 2020-05-20
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2020.05.012
sha: 527d7578db60fc05f1c5a18a4be8bc4bd23bc58e
doc_id: 773050
cord_uid: q92q8zql

nan

patients. 3 Lastly, a single patient was reported with a petechial eruption. 4 The original descriptive 42 study from Wuhan, China noted leukopenia and lymphopenia in 25% and 63% of patients, respectively. 5 43

In this patient, lymphopenia or other stresses related to her underlying illness may have served as a 44 mechanism for reactivation of varicella zoster. The patient's severe herpetic neuralgia is unusual given 45 that she started appropriate antiviral therapy within 12 hours of initial presentation. It may be that her 46 underlying COVID-19 infection contributed to an exaggerated inflammatory response at the dorsal root 47 ganglion, given that the SARS-CoV-2 is known to elicit strong host responses. 48 

Cutaneous manifestations in COVID-19: a first perspective

Varicella-like 52 exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 53 patients

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients

COVID-19 can present with a rash and be mistaken for Dengue

Clinical features of patients infected with 2019 novel coronavirus in Wuhan